| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |